Sumitomo Dainippon Pharma Co (JP:4506) has released an update.
Sumitomo Pharma Co. has concluded its early retirement program aimed at business restructuring, receiving 604 applications against a target of approximately 700. The program will result in a streamlined workforce of around 2,000 employees and entails a financial impact of 5.4 billion yen, recorded as business structure improvement expenses. These expenses are not included in the current financial forecasts for the fiscal year.
For further insights into JP:4506 stock, check out TipRanks’ Stock Analysis page.
